Total Non-Current Liabilities
$8.49B
Quarterly · Period ending: · USD

RPRX Total Non-Current Liabilities
What is total non-current liabilities?
Long-term obligations due beyond one year.
RPRX total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 9,269,630,000 | |
| 6,626,733,000 | |
| 6,136,185,000 | |
| 6,121,310,000 | |
| 7,096,070,000 | |
| 5,816,584,000 | |
| 5,975,040,000 | |
| 6,237,896,000 | |
| 6,520,855,000 | |
| 5,724,690,000 | |
| 5,804,190,000 |
Frequently asked questions: RPRX total non-current liabilities
What is Royalty Pharma plc (RPRX)'s current total non-current liabilities?
Royalty Pharma plc (RPRX)'s latest reported total non-current liabilities (Quarterly) is $8.49B as of Sep 30, 2026. Long-term obligations due beyond one year.
How much historical total non-current liabilities data is available for RPRX?
Stock Alarm Pro provides 11 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s total non-current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare RPRX's total non-current liabilities to peers or set an alert?
You can open RPRX's total non-current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RPRX delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance